您的位置: 首页 > 农业专利 > 详情页

MARCADORES GENÉTICOS PARA LA PREDICCIÓN DE RESPUESTA A LA TERÁPIA.
专利权人:
F. HOFFMANN-LA ROCHE AG
发明人:
Jean-Claude TARDIF,Marie-Pierre DUBÉ,Eric J. NIESOR,Ruchi UPMANYU
申请号:
MX2015013505
公开号:
MX370538B
申请日:
2014.03.24
申请国别(地区):
MX
年份:
2019
代理人:
摘要:
The present invention provides genotyping methods and compositions for selecting patients with cardiovascular disease who will benefit from treatment with HDL-raising or HDL mimicking agent, in particular with a CETP inhibitor/modulator. The present invention provides genotyping methods and compositions for selecting patients with cardiovascular disease who will benefit from treatment with HDL-raising or HDL mimicking agent, in particular with a CETP inhibitor/modulator. The invention relates to a molding mass provided with impact resistance, in particular an impact-resistant PMMA having improved optical properties at elevated temperatures, molded items that can be obtained therefrom, and the use of the molding mass and the molded items.La presente invención se refiere a métodos de genotipo y composiciones para seleccionar pacientes con enfermedad cardiovascular que se beneficiarán del tratamiento con un agente de elevación de HDL o que imita HDL, en particular con un inhibidor/modulador de CETP.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充